Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 2 days ago • ZTS
Zoetis Receives Health Canada Approval for Portelaâ„¢(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
Seeking Alpha • 2 days ago • ZTS
Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Zacks Investment Research • 2 days ago • ZTS
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue?
Zacks Investment Research • 2 days ago • ZTS
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know
Seeking Alpha • 4 days ago • ZTS
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.